Congress approved bill hr3490-119 ("Orders study on esophageal cancer in federal health plans"). Last action: May 29, 2026.
Congress file hr3490-119, before Congress. Passed as of 2026-05-29.
GAO will analyze federal employee cancer coverage patterns The Government Accountability Office must report on esophageal cancer treatment costs under the Federal Employees Health Benefits Program and screening rates among high-risk federal employees and retirees, but this produces information only—no immediate changes to benefits or coverage.
Report may inform future federal health policy decisions Data on FEHBP spending patterns and screening gaps could shape how the federal government addresses cancer detection and treatment in employee health plans, potentially leading to policy changes if screening rates are found to be inadequate.
Report scope limited to federal employees only The analysis covers only FEHBP participants (federal workers and retirees), not the general public, so findings may not apply to other insured or uninsured populations with esophageal cancer.
This bill requires the Government Accountability Office to report to Congress on (1) the impact of esophageal cancer-related health care spending under the Federal Employees Health Benefits Program (FEHBP) for federal employees and retirees diagnosed with esophageal cancer, and (2) how often FEHBP participants with a high risk of esophageal cancer undergo screenings according to established guidelines.
Read the official record for hr3490-119
See everything up for a vote · This week in Congress · See what we have filed with the clerk